Crescent Biopharma (CBIO) EBITDA (2013 - 2026)
Crescent Biopharma (CBIO) reported EBITDA of -$26.3 million for Q2 2026, compared with -$21.03 million a year earlier.
Powered by 
Analysis
Crescent Biopharma (CBIO) EBITDA (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Crescent Biopharma's EBITDA came in at -$168.26 million; for FY2025, it came in at -$152.55 million.
- By year, EBITDA came in at -$40 million in FY2024, -$39.12 million in FY2023, -$47.2 million in FY2022 and -$63.18 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$91.44 million in Q4 2025 and a high of -$8.72 million in Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$24.67 million (Q1 2026), -$91.44 million (Q4 2025) and -$25.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Crescent Biopharma | 401.19 Mn | -306.10 Mn | - | -26.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.30 Mn |
| Mar 31, 2026 | -24.67 Mn |
| Dec 31, 2025 | -91.44 Mn |
| Sep 30, 2025 | -25.86 Mn |
| Jun 30, 2025 | -21.03 Mn |
| Mar 31, 2025 | -14.22 Mn |
| Dec 31, 2024 | -17.19 Mn |
| Sep 30, 2024 | -11.23 Mn |
| Jun 30, 2024 | -10.35 Mn |
| Mar 31, 2024 | -11.10 Mn |
| Dec 31, 2023 | -9.57 Mn |
| Sep 30, 2023 | -9.77 Mn |
| Jun 30, 2023 | -8.89 Mn |
| Mar 31, 2023 | -10.90 Mn |
| Dec 31, 2022 | -10.58 Mn |
| Sep 30, 2022 | -8.72 Mn |
| Jun 30, 2022 | -13.30 Mn |
| Mar 31, 2022 | -14.60 Mn |
| Dec 31, 2021 | -17.36 Mn |
| Sep 30, 2021 | -17.27 Mn |
API Access
Crescent Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();